Harvard Bioscience (HBIO) EBT Margin Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,340.00 |
| Dec 31, 2025 | -1,173.00 |
| Sep 30, 2025 | 38.00 |
| Jun 30, 2025 | -730.00 |
| Mar 31, 2025 | -21,451.00 |
| Dec 31, 2024 | 209.00 |
| Sep 30, 2024 | -1,069.00 |
| Jun 30, 2024 | -1,037.00 |
| Mar 31, 2024 | -1,193.00 |
| Dec 31, 2023 | -405.00 |
| Sep 30, 2023 | 96.00 |
| Jun 30, 2023 | -137.00 |
| Mar 31, 2023 | 2,363.00 |
| Dec 31, 2022 | -94.00 |
| Sep 30, 2022 | -1,387.00 |
| Jun 30, 2022 | 1,557.00 |
| Mar 31, 2022 | -2,024.00 |
| Dec 31, 2021 | 716.00 |
| Sep 30, 2021 | 367.00 |
| Jun 30, 2021 | 77.00 |